New York State Common Retirement Fund
AKBA icon

New York State Common Retirement Fund’s Akebia Therapeutics AKBA Stock Holding History

New York State Common Retirement Fund’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.2K Hold
79,100
– – ﹤0.01% 2752
2026
Q1 		$110K Hold
79,100
– – ﹤0.01% 2484
2025
Q4 		$127K Hold
79,100
– – ﹤0.01% 2496
2025
Q3 		$216K Hold
79,100
– – ﹤0.01% 2261
2025
Q2 		$288K Buy
79,100
+40,700
+106% +$112K ﹤0.01% 2111
2025
Q1 		$73.7K Buy
38,400
+25,900
+207% +$52.9K ﹤0.01% 2650
2024
Q4 		$23.8K Hold
12,500
– – ﹤0.01% 3015
2024
Q3 		$16.5K Sell
12,500
-88,600
-88% -$118K ﹤0.01% 3064
2024
Q2 		$103K Buy
+101,100
New +$125K ﹤0.01% 2774
2022
Q3 		– Sell
-1,595
Closed -$1K – 3261
2022
Q2 		$1K Sell
1,595
-122,402
-99% -$51.4K ﹤0.01% 3309
2022
Q1 		$89K Buy
123,997
+130
+0.1% +$278 ﹤0.01% 3047
2021
Q4 		$280K Buy
123,867
+37,171
+43% +$101K ﹤0.01% 2740
2021
Q3 		$250K Sell
86,696
-33,792
-28% -$96.5K ﹤0.01% 2825
2021
Q2 		$457K Buy
120,488
+1,186
+1% +$3.99K ﹤0.01% 2643
2021
Q1 		$404K Hold
119,302
– – ﹤0.01% 2543
2020
Q4 		$334K Hold
119,302
– – ﹤0.01% 2541
2020
Q3 		$299K Hold
119,302
– – ﹤0.01% 2467
2020
Q2 		$1.62M Buy
119,302
+15,400
+15% +$159K ﹤0.01% 1622
2020
Q1 		$788K Buy
103,902
+7,000
+7% +$54.5K ﹤0.01% 1831
2019
Q4 		$612K Sell
96,902
-24,200
-20% -$115K ﹤0.01% 2187
2019
Q3 		$475K Hold
121,102
– – ﹤0.01% 2360
2019
Q2 		$586K Buy
121,102
+40,800
+51% +$232K ﹤0.01% 2289
2019
Q1 		$658K Hold
80,302
– – ﹤0.01% 2183
2018
Q4 		$444K Buy
80,302
+33,502
+72% +$262K ﹤0.01% 2341
2018
Q3 		$413K Sell
46,800
-15,270
-25% -$137K ﹤0.01% 2497
2018
Q2 		$619K Buy
62,070
+9,400
+18% +$94.1K ﹤0.01% 2359
2018
Q1 		$502K Hold
52,670
– – ﹤0.01% 2354
2017
Q4 		$783K Buy
52,670
+4,570
+10% +$75.8K ﹤0.01% 2159
2017
Q3 		$946K Hold
48,100
– – ﹤0.01% 2032
2017
Q2 		$691K Sell
48,100
-1
-0% -$13 ﹤0.01% 2246
2017
Q1 		$443K Buy
48,101
+11,001
+30% +$107K ﹤0.01% 2437
2016
Q4 		$386K Hold
37,100
– – ﹤0.01% 2483
2016
Q3 		$336K Buy
37,100
+8,900
+32% +$75.7K ﹤0.01% 2528
2016
Q2 		$211K Sell
28,200
-13,842
-33% -$121K ﹤0.01% 2702
2016
Q1 		$379K Buy
42,042
+13,880
+49% +$113K ﹤0.01% 2364
2015
Q4 		$364K Sell
28,162
-3,403
-11% -$34.7K ﹤0.01% 2458
2015
Q3 		$305K Buy
31,565
+2,418
+8% +$22.2K ﹤0.01% 2565
2015
Q2 		$300K Buy
+29,147
New +$249K ﹤0.01% 2758

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

New York State Common Retirement Fund's AKBA Position: Q2 2026 in Review

New York State Common Retirement Fund held its Akebia Therapeutics (AKBA) position steady in Q2 2026 at 79,100 shares worth $90.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

New York State Common Retirement Fund first reported a position in AKBA in Q2 2015 and has held it in 38 quarters since. The position peaked at $1.62M in Q2 2020. 60 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • New York State Common Retirement Fund held 79,100 shares of Akebia Therapeutics worth $90.2K as of Q2 2026.
  • New York State Common Retirement Fund left its Akebia Therapeutics share count unchanged in Q2 2026.
  • Akebia Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2752 holding.
  • New York State Common Retirement Fund first reported a position in Akebia Therapeutics in Q2 2015 and has held it in 38 quarters since.
  • New York State Common Retirement Fund's Akebia Therapeutics position peaked at $1.62M in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.